SCHEMBL24327018

SCHEMBL24327018

O=S1(=O)N2CCCc3cccc(c32)N1c1nc(Cl)ncc1Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 2/20 0.43
HTR1A P08908 1/20 0.43
DRD2 P14416 1/20 0.43
HTR7 P34969 1/20 0.43
HTR6 P50406 1/20 0.43
ALDH1A1 P00352 3/20 0.34
MAPK1 P28482 2/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
SMN1; SMN2 Q16637 3/20 0.33
LMNA P02545 2/20 0.33
KMT2A Q03164 2/20 0.33
KDM4E B2RXH2 1/20 0.33
GMNN O75496 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
MAPT P10636 1/20 0.33
CYP2C9 P11712 1/20 0.33
ALOX15 P16050 1/20 0.33
SLC6A4 P31645 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24327019 0.73 ALDH1A1 (0.33) ALDH1A1MAPK1L3MBTL1SMN1; SMN2LMNA
SCHEMBL30919743 0.72 ROCK1 (0.49) ALDH1A1MAPK1L3MBTL1SMN1; SMN2LMNA
SCHEMBL4850144 0.71 HTR2A (0.47) HTR2AHTR1ADRD2HTR7HTR6
SCHEMBL9726206 0.67 HTR2A (0.62) HTR2AHTR1ADRD2HTR7HTR6
SCHEMBL25499920 0.67 NPC1 (0.53) ALDH1A1MAPK1SMN1; SMN2LMNAMAPT
SCHEMBL29651265 0.67 NPC1 (0.53) ALDH1A1MAPK1SMN1; SMN2LMNAMAPT
SCHEMBL7793840 0.66 HTR2A (0.59) HTR2AHTR1ADRD2HTR7HTR6
SCHEMBL9726221 0.66 HTR2A (0.64) HTR2AHTR1ADRD2HTR7HTR6
SCHEMBL28743736 0.66 NOTUM (0.41) HTR2ADRD2ALDH1A1SMN1; SMN2KMT2A
SCHEMBL29651175 0.66 NOTUM (0.41) HTR2ADRD2ALDH1A1SMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022063106-A1 INDOLINE COMPOUNDS AND DERIVATIVES AS EGFR INHIBITORS BEIGENE, LTD. (KY) 2022-03-31 WO disclosed